Filed: 2/14/2025ACC: 0000950123-25-002355
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $120.71M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$120.71M
Total AUM (reported)
25.07M
Total Shares
Allocation by class
COMMON STOCK$85.66M71.0%
COMMON STOCK CLASS A$34.77M28.8%
WARRANT$271.1K0.2%
Portfolio Concentration
Top 3$97.10M80.4%
4–10$23.55M19.5%
11–25$57.8K0.0%
Top 3 weight
80.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 25.07M
Sole
Full voting authority
25.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
Bicara Therapeutics Inc.
SOLEShares2.20M
TypeSH
Market value$38.41M
31.82%
Sole
2.20M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares13.07M
TypeSH
Market value$34.77M
28.81%
Sole
13.07M
Shared
0.00
None
0.00
Replimune Group
SOLEShares1.98M
TypeSH
Market value$23.92M
19.82%
Sole
1.98M
Shared
0.00
None
0.00
Lexeo Therapeutics
SOLEShares1.18M
TypeSH
Market value$7.79M
6.46%
Sole
1.18M
Shared
0.00
None
0.00
Alumis Inc
SOLEShares653.22K
TypeSH
Market value$5.13M
4.25%
Sole
653.22K
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$3.69M
3.06%
Sole
2.25M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares526.36K
TypeSH
Market value$3.50M
2.90%
Sole
526.36K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$1.79M
1.48%
Sole
1.79M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$1.38M
1.14%
Sole
843.75K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares321.50K
TypeSH
Market value$271.1K
0.22%
Sole
321.50K
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$57.8K
0.05%
Sole
251.27K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 2.20M | SH | $38.41M 31.82% | 2.20M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 13.07M | SH | $34.77M 28.81% | 13.07M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 1.98M | SH | $23.92M 19.82% | 1.98M | 0.00 | 0.00 |
Lexeo TherapeuticsSOLE | Common Stock | 1.18M | SH | $7.79M 6.46% | 1.18M | 0.00 | 0.00 |
Alumis IncSOLE | Common Stock | 653.22K | SH | $5.13M 4.25% | 653.22K | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $3.69M 3.06% | 2.25M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 526.36K | SH | $3.50M 2.90% | 526.36K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $1.79M 1.48% | 1.79M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $1.38M 1.14% | 843.75K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 321.50K | SH | $271.1K 0.22% | 321.50K | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $57.8K 0.05% | 251.27K | 0.00 | 0.00 |